FDA expands approved use of drug to treat liver cancer
On April 27, the U.S. Food and Drug Administration (FDA) expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular…
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.